- Home
- YJ vs APRE Comparison
YJ vs APRE Comparison
Compare YJ & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- APRE
- Stock Information
- Founded
- YJ 2015
- APRE 2006
- Country
- YJ China
- APRE United States
- Employees
- YJ N/A
- APRE N/A
- Industry
- YJ Other Specialty Stores
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YJ Consumer Discretionary
- APRE Health Care
- Exchange
- YJ Nasdaq
- APRE Nasdaq
- Market Cap
- YJ 10.1M
- APRE 9.4M
- IPO Year
- YJ 2019
- APRE 2019
- Fundamental
- Price
- YJ $1.74
- APRE $1.56
- Analyst Decision
- YJ
- APRE Strong Buy
- Analyst Count
- YJ 0
- APRE 1
- Target Price
- YJ N/A
- APRE $20.00
- AVG Volume (30 Days)
- YJ 9.6K
- APRE 54.2K
- Earning Date
- YJ 08-21-2025
- APRE 08-12-2025
- Dividend Yield
- YJ N/A
- APRE N/A
- EPS Growth
- YJ N/A
- APRE N/A
- EPS
- YJ N/A
- APRE N/A
- Revenue
- YJ $47,760,127.00
- APRE $841,012.00
- Revenue This Year
- YJ N/A
- APRE N/A
- Revenue Next Year
- YJ N/A
- APRE N/A
- P/E Ratio
- YJ N/A
- APRE N/A
- Revenue Growth
- YJ N/A
- APRE N/A
- 52 Week Low
- YJ $1.37
- APRE $1.41
- 52 Week High
- YJ $2.73
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- YJ 48.10
- APRE 40.41
- Support Level
- YJ $1.67
- APRE $1.53
- Resistance Level
- YJ $1.75
- APRE $1.70
- Average True Range (ATR)
- YJ 0.06
- APRE 0.08
- MACD
- YJ 0.00
- APRE -0.01
- Stochastic Oscillator
- YJ 40.91
- APRE 11.06
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.